Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder
Saved in:
Namchuk, A.B., et al., Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder. Adar, volume 2, 2022, p. 1-16.
Ref.
588688
Location:
SIIS Archivo
Palabras clave:
Trastornos, Discapacidad, Depresión, Salud mental, Unión Europea
Trastornos, Discapacidad, Depresión, Salud mental, Unión Europea
Abstract:
Rates of major depressive disorder (MDD) are disproportionally high in subjects with opioid use disorder (OUD) relative to the general population. MDD is often more severe in OUD patients, leading to compliance issues with maintenance therapies and poor outcomes
Rates of major depressive disorder (MDD) are disproportionally high in subjects with opioid use disorder (OUD) relative to the general population. MDD is often more severe in OUD patients, leading to compliance issues with maintenance therapies and poor outcomes
Be the first to leave a comment!